SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2022 on May 10, 2022
SOPHiA GENETICS (Nasdaq: SOPH) will announce its financial results for Q1 2022 on May 10, 2022, before U.S. market opening. A conference call will follow at 8:30 a.m. ET to discuss the results and future business outlook. The call will be available for live webcasting on the company's Investor Relations website. SOPHiA is committed to data-driven medicine and its SOPHiA DDM™ Platform is utilized by over 790 healthcare institutions worldwide.
- SOPHiA GENETICS is set to release Q1 2022 financial results, indicating ongoing engagement with investors.
- The company's SOPHiA DDM™ Platform is utilized by over 790 healthcare institutions, showcasing its market reach and adoption.
- None.
BOSTON and LAUSANNE, Switzerland, April 13, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal 2022 before U.S. markets open on Tuesday, May 10, 2022. SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:30 a.m. Eastern Time / 2:30 p.m. Central European Time.
The call will be webcast live on the SOPHiA GENETICS Investor Relations website. Additionally, a replay will be available on the website after its completion.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by over 790 hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn and Instagram. Where others see data, we see answers.
Investor Contact:
Jennifer Pottage
Head of Investor Relations
Jpottage@sophiagenetics.com
Media Contact:
Eliza Bamonti
Director of Public Relations
Ebamonti@sophiagenetics.com
FAQ
When will SOPHiA GENETICS release its Q1 2022 financial results?
What time is the SOPHiA GENETICS conference call for Q1 2022 results?
How can I access the SOPHiA GENETICS Q1 2022 financial results call?
What is the SOPHiA DDM™ Platform?
